Keyword Analysis & Research: translarna canada

ptcbio.com

https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-provides-updates-translarnatm-regulatory

WEBDec 5, 2023 · Translarna (ataluren), discovered and developed by PTC Therapeutics, is a protein restoration therapy designed to enable the formation of a functioning protein in … canada

canada

DA: 41 PA: 39 MOZ Rank: 70

prnewswire.com

https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-update-on-health-canada-review-of-translarna-ataluren-for-the-treatment-of-duchenne-muscular-dystrophy-300235219.html

WEBMar 14, 2016 · Translarna, discovered and developed by PTC Therapeutics, Inc., is a protein restoration therapy designed to enable the formation of a functioning protein in patients …

DA: 41 PA: 3 MOZ Rank: 26

ptcbio.com

https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-provides-updates-translarnatm-regulatory

DA: 29 PA: 35 MOZ Rank: 28

ptcbio.com

https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-provides-update-health-canada-review

WEBMar 14, 2016 · Translarna is licensed in the European Economic Area for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients aged five years …

DA: 82 PA: 94 MOZ Rank: 33

prnewswire.com

https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-clinical-and-real-world-evidence-on-translarna-at-the-annual-congress-of-the-world-muscle-society-301645587.html

WEBOct 11, 2022 · Translarna (ataluren), discovered and developed by PTC Therapeutics, is a protein restoration therapy designed to enable the formation of a functioning protein in …

DA: 32 PA: 40 MOZ Rank: 84

wikipedia.org

https://en.wikipedia.org/wiki/Ataluren

OverviewMedical useContraindicationsAdverse effectsInteractionsPharmacologyChemistryHistoryAtaluren is used in the European Union to treat people with Duchenne muscular dystrophy who have a nonsense mutation in the dystrophin gene, can walk, and are more than five years old. Routes of administration: By mouth: Molar mass: 284.246 g·mol−1 Formula: C₁₅H₉FN₂O₃ Trade names: Translarna canada

Routes of administration: By mouth:

Molar mass: 284.246 g·mol−1

Formula: C₁₅H₉FN₂O₃

Trade names: Translarna

canada

DA: 23 PA: 62 MOZ Rank: 29

europa.eu

https://www.ema.europa.eu/en/medicines/human/EPAR/translarna

WEBSep 4, 2014 · Translarna is a medicine that is used to treat patients aged 2 years and older with Duchenne muscular dystrophy who are able to walk. Duchenne muscular dystrophy is … canada

canada

DA: 30 PA: 11 MOZ Rank: 69

defeatdmdnow.ca

https://defeatdmdnow.ca/

WEBDespite the fact that new therapies – Translarna (ataluren) and Exondys 51 (eteplirsen) – have been approved in Europe and the United States for several years now, in Canada we are …

DA: 92 PA: 11 MOZ Rank: 88

biospace.com

https://www.biospace.com/article/with-new-data-ptc-therapeutics-preps-to-resubmit-dmd-drug-translarna-to-fda/

WEBPublished: Jun 21, 2022 By Alex Keown. Translarna is going for another FDA approval review. For years, PTC Therapeutics has attempted to win regulatory approval for its Duchenne … canada

canada

DA: 46 PA: 6 MOZ Rank: 40

ptcbio.com

https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-present-clinical-and-real-world-evidence

WEBOct 11, 2022 · Translarna (ataluren), discovered and developed by PTC Therapeutics, is a protein restoration therapy designed to enable the formation of a functioning protein in …

DA: 1 PA: 62 MOZ Rank: 19